Therefore, RTK inhibitors might negatively regulate PI3K signaling.53 However, many types of cancer are always resistant to a single RTK inhibitor because PI3K is activated by multiple RTKs in cancer.54 Therefore, understanding RTK signaling networks will facilitate a better comprehension of the PI3K pathway and further exploration of cancer therapies. The gene discussed is PIK3CD; the disease is cancer.